732509318	732509318	CD	B-NP	O
|	|	NN	I-NP	O
TMC	TMC	NN	I-NP	O
|	|	NN	I-NP	O
00531532	00531532	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2434111	2434111	CD	B-NP	O
|	|	CC	I-NP	O
2/24/2006	2/24/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ESRD	ESRD	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/17/2006	4/17/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/2/2006	2/2/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
WETHERN	WETHERN	NNP	B-NP	O
,	,	,	O	O
GERARDO	GERARDO	NNP	B-NP	O
108-95-46-4	108-95-46-4	CD	I-NP	O
Woodlancla	Woodlancla	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/18/06	1/18/06	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LUBERGER	LUBERGER	NNP	B-NP	O
,	,	,	O	O
SYLVESTER	SYLVESTER	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
25	25	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
EMFINGER	EMFINGER	NN	B-NP	O
,	,	,	O	O
MURRAY	MURRAY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
610312553	610312553	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
atrial	atrial	JJ	B-NP	O
fludder	fludder	NN	I-NP	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	I-NP	O
250	250	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q12H	Q12H	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
GILLICH	GILLICH	NN	B-NP	O
,	,	,	O	O
ERASMO	ERASMO	NN	B-NP	B-protein
D.	D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
610312553	610312553	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
atrial	atrial	JJ	B-NP	O
fludder	fludder	NN	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/12/06	2/12/06	CD	B-NP	O
by	by	IN	B-PP	O
ELWARD	ELWARD	NNP	B-NP	O
,	,	,	O	O
HARVEY	HARVEY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SEVELAMER	SEVELAMER	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
VASOTEC	VASOTEC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
by	by	IN	B-PP	O
BELARDE	BELARDE	NNP	B-NP	O
,	,	,	O	O
JEFFREY	JEFFREY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
VASOTEC	VASOTEC	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
381638532	381638532	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
COUGH	COUGH	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
takes	take	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
ADVAIR	ADVAIR	NN	I-NP	O
DISKUS	DISKUS	VBZ	B-VP	O
250/50	250/50	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
HUMALOG	HUMALOG	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
18	18	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
at	at	IN	B-PP	O
dinnertime	dinnertime	NNP	B-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
N	N	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/29	10/29	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
N	N	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
25	25	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	I-protein
COZAAR	COZAAR	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LOSARTAN	LOSARTAN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-NP	O
60	60	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
PROTONIX	PROTONIX	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LYRICA	LYRICA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PREGABALIN	PREGABALIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
SEVELAMER	SEVELAMER	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
dose	dose	NN	B-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/12/06	2/12/06	CD	B-NP	O
by	by	IN	B-PP	O
ZURITA	ZURITA	NNP	B-NP	O
,	,	,	O	O
JEAN	JEAN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
863908816	863908816	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SEVELAMER	SEVELAMER	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
TRAMADOL	TRAMADOL	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q6H	Q6H	NN	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
NAS	NAS	NN	I-NP	B-protein
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
/	/	SYM	B-NP	O
Renal	Renal	JJ	I-NP	O
diet	diet	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dialysis	Dialysis	NN	B-NP	O
9/12/20	9/12/20	CD	I-NP	O
at	at	IN	B-PP	O
MRVH	MRVH	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Victorin	Victorin	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
at	at	IN	B-PP	O
Lebendlynsu	Lebendlynsu	NNP	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
De	De	NNP	B-NP	O
Quechpro	Quechpro	NNP	I-NP	O
Derdtopesterl	Derdtopesterl	NNP	I-NP	O
,	,	,	O	O
Idaho	Idaho	NNP	B-NP	O
82620	82620	CD	B-NP	O
10/19	10/19	CD	I-NP	O
at	at	IN	B-PP	O
4pm	4pm	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Boxwell	Boxwell	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
at	at	IN	B-PP	O
LH	LH	NN	B-NP	B-DNA
8/21	8/21	CD	I-NP	I-DNA
at	at	IN	B-PP	O
12	12	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Rokus	Rokus	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Vascular	Vascular	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
at	at	IN	B-PP	O
SH	SH	NN	B-NP	O
2/28	2/28	CD	I-NP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
FLUORESCEIN	FLUORESCEIN	NN	B-NP	O
DYE	DYE	NN	I-NP	O
,	,	,	O	O
TETRACYCLINE	TETRACYCLINE	NN	B-NP	O
ANALOGUES	ANALOGUES	NNS	I-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
ESRD	ESRD	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ESRD	ESRD	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	B-protein
Dx	Dx	NN	I-NP	I-protein
`	`	``	O	I-protein
89	89	CD	B-NP	I-protein
DM	DM	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
dependent	dependent	JJ	I-NP	O
Dx	Dx	NN	I-NP	O
`	`	``	O	O
89	89	CD	B-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
L	L	NN	I-NP	O
knee	knee	NN	I-NP	O
DJD	DJD	NN	I-NP	O
nephrotic	nephrotic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
4/8	4/8	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
nephrotic	nephrotic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
medullary	medullary	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
7/4	7/4	CD	I-NP	O
right	right	JJ	I-NP	O
PICA	PICA	NN	I-NP	O
7/4	7/4	CD	I-NP	O
Echo-mod	Echo-mod	NN	I-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NNP	I-NP	O
Anemia	Anemia	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
N/A	N/A	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Fistulogram	Fistulogram	NNP	B-NP	O
and	and	CC	I-NP	O
Angioplasty	Angioplasty	NNP	I-NP	O
of	of	IN	B-PP	O
Fistula	Fistula	NNP	B-NP	O
4/25	4/25	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

New	New	NNP	B-NP	O
tunneled	tunnel	VBD	B-VP	O
catheter	catheter	RBR	B-NP	B-protein
11/3	11/3	CD	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Initiation	Initiation	NN	B-NP	O
of	of	IN	B-PP	O
Dialysis	Dialysis	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
*****	*****	SYM	B-VP	O
HPI	HPI	NN	B-NP	O
55	55	CD	I-NP	O
y/o	y/o	NN	I-NP	O
female	female	JJ	I-NP	O
patient	patient	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
h/o	h/o	NN	I-NP	O
CRI	CRI	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
DM	DM	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
retinopathy	retinopathy	NN	I-NP	O
,	,	,	O	O
diabetic	diabetic	JJ	B-NP	O
nephropathy	nephropathy	NN	I-NP	O
and	and	CC	O	O
diabetic	diabetic	JJ	B-NP	O
PNP	PNP	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
and	and	CC	O	O
s/p	s/p	NN	B-NP	O
medullary	medullary	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
due	due	IN	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
Crea	Crea	NNP	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
reveald	reveald	VBP	B-VP	O
during	during	IN	B-PP	O
routine	routine	JJ	B-NP	O
blood	blood	NN	I-NP	O
work.Her	work.Her	NN	I-NP	O
CK	CK	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
at	at	IN	B-PP	O
269	269	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
LDH	LDH	NN	I-NP	B-protein
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
376	376	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
Lyrics	Lyrics	NNP	B-NP	O
recently	recently	RB	B-ADVP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
PNP	PNP	NN	I-NP	B-protein
and	and	CC	O	O
,	,	,	O	O
since	since	IN	B-SBAR	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
every	every	DT	B-NP	O
hour	hour	NN	I-NP	O
for	for	IN	B-PP	O
urination	urination	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
or	or	CC	O	O
night	night	NN	B-NP	O
sweats	sweat	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
denied	deny	VBD	B-VP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
or	or	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
****	****	SYM	B-VP	O
PMH	PMH	NN	B-NP	O
HTN	HTN	NN	I-NP	O
Dx	Dx	NN	I-NP	O
`	`	``	O	O
89	89	CD	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
dependent	dependent	JJ	I-NP	O
w/diabetic	w/diabetic	JJ	I-NP	O
retinopathy	retinopathy	NN	I-NP	O
,	,	,	O	O
nephropathy	nephropathy	NN	B-NP	O
and	and	CC	O	O
PNP	PNP	NN	B-NP	B-protein
Dx	Dx	NN	I-NP	I-protein
`	`	``	O	O
89	89	CD	B-NP	O
,	,	,	O	O
Obesity	Obesity	NNP	B-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
knee	knee	NNP	I-NP	O
DJD	DJD	NNP	I-NP	O
,	,	,	O	O
Nephrodic	Nephrodic	JJ	B-NP	B-protein
syndrome	syndrome	NN	I-NP	I-protein
4/8	4/8	CD	I-NP	I-protein
,	,	,	O	O
Hypercholesterolemia	Hypercholesterolemia	NNP	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
medullary	medullary	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
7/4	7/4	CD	I-NP	O
right	right	JJ	I-NP	O
Pica	Pica	NNP	I-NP	O
,	,	,	O	O
Anemia	Anemia	NNP	B-NP	O
?	?	.	O	O
etiology	etiology	NNP	B-NP	O
22	22	CD	I-NP	O
of	of	IN	B-PP	O
June	June	NNP	B-NP	O
****	****	NNP	I-NP	O
ALL	ALL	NNP	I-NP	O
:	:	:	O	O
Fluorescein	Fluorescein	NN	B-NP	O
dye	dye	NN	I-NP	O
,	,	,	O	O
unknown	unknown	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
Tetracycline	Tetracycline	NN	I-NP	O
analogs	analog	NNS	I-NP	O
,	,	,	O	O
unknown	unknown	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
Lisinopril	Lisinopril	NNP	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
IV	IV	CD	I-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
anaphylaxis	anaphylaxis	NN	B-NP	B-protein
****	****	SYM	B-NP	I-protein
MEDS	MEDS	NN	I-NP	I-protein
at	at	IN	B-PP	I-protein
admission	admission	NN	B-NP	I-protein
Amitryptiline	Amitryptiline	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
Calcitriol	Calcitriol	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QOD	QOD	NN	I-NP	I-protein
Cozaar	Cozaar	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Ecasa	Ecasa	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Epo	Epo	NNP	I-NP	B-protein
5000U	5000U	NNP	I-NP	O
SC	SC	NNP	I-NP	O
Qweek	Qweek	NNP	I-NP	O
Fes04	Fes04	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Humalog	Humalog	NN	I-NP	O
insulin	insulin	NN	I-NP	O
prefilled	prefille	VBD	B-VP	O
pens	pen	VBZ	B-VP	O
18	18	CD	B-NP	O
U	U	NN	I-NP	O
and	and	CC	I-NP	O
adjust	adjust	NN	I-NP	O
as	as	IN	B-PP	O
directed	direct	VBN	B-NP	O
SC	SC	NN	I-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
dinner	dinner	NN	I-NP	O
Insulin	Insulin	NN	I-NP	O
NPH	NPH	NN	I-NP	O
human	human	JJ	I-NP	O
50	50	CD	I-NP	O
U	U	NN	I-NP	O
w/breakfast	w/breakfast	NN	I-NP	O
,	,	,	O	O
25	25	CD	B-NP	O
U	U	NN	I-NP	O
at	at	IN	B-PP	O
hrs	hr	NNS	B-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
Metolazone	Metolazone	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Metoprolol	Metoprolol	NN	I-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
Nifedipine	Nifedipine	NN	I-NP	O
XL	XL	NN	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Protonix	Protonix	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
DR	DR	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Renagel	Renagel	NNP	I-NP	O
800	800	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
Vasotec	Vasotec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
****	****	SYM	B-NP	O
SHx	SHx	NN	I-NP	O
:	:	:	O	O
married	marry	VBN	B-VP	O
,	,	,	O	O
12	12	CD	B-NP	O
y/o	y/o	NN	I-NP	O
son	son	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
h/o	h/o	NN	I-NP	O
alcohol	alcohol	NN	I-NP	O
,	,	,	O	O
nicotine	nicotine	NN	B-NP	O
or	or	CC	O	O
illicit	illicit	JJ	B-NP	O
drug	drug	NN	I-NP	O
abuse	abuse	NN	I-NP	O
****	****	SYM	B-NP	O
FH	FH	NN	I-NP	O
:	:	:	O	O
Father	Father	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
attack	attack	NN	I-NP	O
;	;	:	O	O
mothers	mother	NNS	B-NP	O
and	and	CC	I-NP	O
sisters	sister	NNS	I-NP	O
have	have	VBP	B-VP	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
DM	DM	NN	I-NP	O
****	****	SYM	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Tmax	Tmax	NN	B-NP	O
98.4	98.4	CD	I-NP	O
T	T	NN	I-NP	O
97s-98s	97s-98	NNS	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	B-protein
90s-110s	90s-110	NNS	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	O
110-120/60	110-120/60	CD	I-NP	O
-70	-70	CD	I-NP	O
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
,	,	,	O	O
O2	O2	NN	B-NP	O
93-100	93-100	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
FFS	FFS	NN	B-NP	O
212	212	CD	I-NP	O
Obese	Obese	NN	I-NP	O
.	.	.	O	O

NAD	NAD	NN	B-NP	O
.	.	.	O	O

CTAB	CTAB	NN	B-NP	B-protein
.	.	.	O	O

RRR	RRR	NN	B-NP	O
S1/S2	S1/S2	NN	I-NP	O
.	.	.	O	O

S/NT/ND	S/NT/ND	NN	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
statis	statis	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

****	****	SYM	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
tachycardia	tachycardia	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fludder	fludder	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
block	block	NN	I-NP	O
2/12/06	2/12/06	CD	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
:	:	:	O	O
E.coli	E.coli	NNP	B-NP	O
>	>	SYM	O	O
100.000	100.000	CD	B-NP	O
TCC	TCC	NN	I-NP	B-protein
,	,	,	O	O
Echo	Echo	NNP	B-NP	O
10/22/06	10/22/06	CD	I-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
calcification	calcification	NN	B-NP	O
of	of	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
and	and	CC	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
.	.	.	O	O

no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
for	for	IN	B-PP	O
perIcarditis	perIcarditis	NN	B-NP	O
.	.	.	O	O

Final	Final	JJ	B-NP	O
report	report	NN	I-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

Fistulogramm	Fistulogramm	NNP	B-NP	O
9/14/06	9/14/06	CD	I-NP	O
:	:	:	O	O
blockage	blockage	NN	B-NP	O
found	find	VBN	B-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
ballon-dilated	ballon-dilated	JJ	B-ADJP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
Impression	Impression	NN	I-NP	O
:	:	:	O	O
55F	55F	NN	B-NP	O
with	with	IN	B-PP	O
CRI	CRI	NN	B-NP	O
p/w	p/w	NN	I-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
CKD	CKD	NN	B-NP	B-protein
to	to	TO	B-PP	O
ESRD	ESRD	NNP	B-NP	O
.	.	.	O	O

UTI	UTI	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
contributing	contribute	VBG	I-VP	O
factor	factor	NN	B-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
initiated	initiate	VBN	B-NP	O
HD	HD	NN	I-NP	O
.	.	.	O	O

****	****	SYM	O	O
Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
CARDIAC	CARDIAC	NN	B-NP	O
:	:	:	O	O
Mildly	Mildly	RB	B-NP	O
tachycardic	tachycardic	JJ	I-NP	O
in-house	in-house	NN	I-NP	O
,	,	,	O	O
going	go	VBG	B-VP	O
in	in	IN	B-PP	O
and	and	CC	B-PP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
Atrial	Atrial	NNP	B-NP	O
Flutter	Flutter	NNP	I-NP	O
and	and	CC	O	O
Atrial	Atrial	NNP	B-NP	O
Fibrillation	Fibrillation	NNP	I-NP	O
.	.	.	O	O

Beta	Beta	NNP	B-NP	O
Blocker	Blocker	NNP	I-NP	O
titrated	titrate	VBD	B-VP	O
to	to	TO	B-PP	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
BID	BID	NN	I-NP	O
with	with	IN	B-PP	O
satisfactory	satisfactory	JJ	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Nifedipine	Nifedipine	NN	B-NP	O
and	and	CC	I-NP	O
Metolazone	Metolazone	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in-house	in-house	JJ	B-ADJP	O
,	,	,	O	O
given	give	VBN	B-PP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
BP	BP	NN	B-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
BP	BP	NN	I-NP	I-protein
remained	remain	VBD	B-VP	O
well-controlled	well-controlled	JJ	B-ADJP	O
despite	despite	IN	B-PP	O
her	her	PRP	B-NP	O
being	be	VBG	B-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
asymptomatic	asymptomatic	JJ	I-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
to	to	TO	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
and	and	CC	I-NP	O
IGMC	IGMC	NN	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
WNL	WNL	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
also	also	RB	B-ADVP	O
unremarkable	unremarkable	JJ	B-ADJP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
ARF	ARF	NN	B-NP	B-protein
,	,	,	O	O
likely	likely	RB	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
CKD	CKD	NN	B-NP	B-protein
with	with	IN	B-PP	O
UTI	UTI	NN	B-NP	O
contributory	contributory	JJ	I-NP	O
cause	cause	NN	I-NP	O
.	.	.	O	O

Initiated	Initiate	VBN	B-NP	O
dialysis	dialysis	NN	I-NP	O
on	on	IN	B-PP	O
10/13	10/13	CD	B-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
dialysis	dialysis	NN	I-NP	O
on	on	IN	B-PP	O
5/24	5/24	CD	B-NP	O
noted	note	VBD	B-VP	O
poor	poor	JJ	B-NP	O
flow	flow	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
to	to	TO	B-PP	O
IR	IR	NN	B-NP	B-protein
for	for	IN	B-PP	O
fistulogram	fistulogram	NN	B-NP	O
.	.	.	O	O

Fistulogram	Fistulogram	NNP	B-NP	O
revealed	reveal	VBD	B-VP	O
stenosis	stenosis	NN	B-NP	O
of	of	IN	B-PP	O
graft	graft	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
angioplastied	angioplastie	VBN	I-VP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
flow	flow	NN	I-NP	O
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
HD	HD	NN	B-NP	O
catheter	catheter	NN	I-NP	O
on	on	IN	B-PP	O
11/3	11/3	NN	B-NP	O
as	as	IN	B-PP	O
access	access	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
graft	graft	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
difficult	difficult	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
f/u	f/u	VBN	I-VP	O
with	with	IN	B-PP	O
vascular	vascular	JJ	B-NP	B-protein
surgery	surgery	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
Tienda	Tienda	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
graft	graft	NN	I-NP	O
correction	correction	NN	I-NP	O
in	in	IN	B-PP	O
near	near	JJ	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	I-NP	O
Cozaar	Cozaar	NNP	I-NP	O
and	and	CC	I-NP	O
Vasotec	Vasotec	NNP	I-NP	O
,	,	,	O	O
per	per	IN	B-PP	O
renal	renal	JJ	B-ADJP	O
.	.	.	O	O

Sevelamer	Sevelamer	NN	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
1200	1200	CD	B-NP	O
TID	TID	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
slight	slight	JJ	B-NP	O
hyperphosphatemia	hyperphosphatemia	NN	I-NP	O
.	.	.	O	O

ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
notes	note	VBZ	B-VP	O
potential	potential	JJ	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
dye	dye	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
12	12	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
fistulogram	fistulogram	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
fistulogram	fistulogram	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
E	E	NNP	B-NP	O
Coli	Coli	NNP	I-NP	O
UTI	UTI	NNP	I-NP	O
.	.	.	O	O

Treating	Treat	VBG	B-VP	O
with	with	IN	B-PP	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NN	B-NP	O
:	:	:	O	O
Continued	Continue	VBN	B-NP	O
insulin	insulin	NN	I-NP	B-protein
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
morning	morning	NN	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
FS	FS	NN	B-NP	O
30-50s	30-50s	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
evening	evening	NN	I-NP	O
NPH	NPH	NN	I-NP	O
were	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in-house	in-house	JJ	B-ADJP	O
.	.	.	O	O

These	These	DT	B-NP	O
episodes	episode	NNS	I-NP	O
were	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	B-protein
POs	PO	NNS	I-NP	I-protein
and	and	CC	O	O
repeated	repeat	VBN	B-VP	O
runs	run	NNS	B-NP	O
of	of	IN	B-PP	O
NPO	NPO	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in-house	in-house	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
resume	resume	VB	I-VP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
Begun	Begun	NN	B-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
for	for	IN	B-PP	O
new	new	JJ	B-NP	O
AFib	AFib	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
drawn	draw	VBN	B-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
WMH	WMH	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
204	204	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
273-3408	273-3408	CD	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
her	her	PRP$	B-NP	O
INRs	INR	NNS	I-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
target	target	NN	B-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
Renal	Renal	JJ	B-NP	O
diet	diet	NN	I-NP	O
+	+	SYM	B-NP	O
diabetic	diabetic	JJ	I-NP	O
+	+	SYM	I-NP	O
low	low	JJ	I-NP	O
fat	fat	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
PPI	PPI	NN	B-NP	B-protein
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000U	5000U	NN	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
colace	colace	NN	B-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
DISPO	DISPO	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
with	with	IN	B-PP	O
Home	Home	NN	B-NP	O
PT	PT	NN	I-NP	O
services	service	NNS	I-NP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	JJ	B-NP	O
dialysis	dialysis	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
by	by	IN	B-PP	O
your	your	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
doctors	doctor	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Take	Take	VB	B-VP	O
coumadin	coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

See	See	VB	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Gofton	Gofton	NNP	I-NP	O
on	on	IN	B-PP	O
10/19	10/19	CD	B-NP	O
at	at	IN	B-PP	O
4pm	4pm	NN	B-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
will	will	MD	B-VP	O
draw	draw	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
check	check	VB	B-VP	O
an	an	DT	B-NP	O
``	``	``	I-NP	B-DNA
INR	INR	NN	I-NP	I-DNA
''	''	''	O	I-DNA
and	and	CC	O	O
send	send	VB	B-VP	O
it	it	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
DRH	DRH	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
service	service	NN	I-NP	O
will	will	MD	B-VP	O
then	then	RB	I-VP	O
call	call	VB	I-VP	O
you	you	PRP	B-NP	O
and	and	CC	O	O
tell	tell	VB	B-VP	O
you	you	PRP	B-NP	O
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
new	new	JJ	I-NP	O
medicines	medicine	NNS	I-NP	O
are	be	VBP	B-VP	O
:	:	:	O	O
Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Sevelamer	Sevelamer	NN	B-NP	O
1200	1200	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

STOP	STOP	NN	B-NP	O
Nifedipine	Nifedipine	NN	I-NP	O
and	and	CC	O	O
Metolazone	Metolazone	NN	B-NP	O
until	until	IN	B-SBAR	O
you	you	PRP	B-NP	O
see	see	VBP	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Hawelu	Hawelu	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
service	service	NN	I-NP	O
at	at	IN	B-PP	O
ETJMC	ETJMC	NNP	B-NP	B-cell_type
will	will	MD	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
o/p	o/p	NN	B-NP	O
dialysis	dialysis	NN	I-NP	O
-	-	HYPH	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
meantime	meantime	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
get	get	VB	I-VP	O
HD	HD	NN	B-NP	O
at	at	IN	B-PP	O
HVH	HVH	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
:	:	:	O	O
INR	INR	NN	B-NP	B-protein
eventually	eventually	RB	B-ADVP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
regularly	regularly	RB	B-ADVP	O
at	at	IN	B-PP	O
PCP	PCP	NN	B-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
call	call	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
to	to	TO	B-PP	O
IH	IH	NNP	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
107-568-5779	107-568-5779	CD	B-NP	O
-	-	HYPH	O	O
they	they	PRP	B-NP	O
will	will	MD	B-VP	O
instruct	instruct	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
vary	vary	VB	I-VP	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	O	O
to	to	TO	B-VP	O
target	target	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
2-3	2-3	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GRAFT	GRAFT	NN	B-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
see	see	VBP	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Pazik	Pazik	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
vascular	vascular	JJ	I-NP	B-protein
surgery	surgery	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
at	at	IN	B-PP	O
GCH	GCH	NN	B-NP	O
on	on	IN	B-PP	O
2/28	2/28	CD	B-NP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
pm	pm	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
revision	revision	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
graft	graft	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
draw	draw	NN	I-NP	I-protein
initial	initial	JJ	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
while	while	IN	B-SBAR	O
her	her	PRP$	B-NP	O
eventual	eventual	JJ	I-NP	O
draws	draw	NNS	I-NP	O
at	at	IN	B-PP	O
PCP	PCP	NN	B-NP	O
office	office	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
set	set	VBN	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
RAPELYEA	RAPELYEA	NN	B-NP	O
,	,	,	O	O
EMILIO	EMILIO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QO80	QO80	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/18/06	1/18/06	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
01	01	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

